Literature DB >> 12867560

Identification and evaluation of LPS antigen for serodiagnosis of uveitis associated with leptospirosis.

C Gowri Priya1, K Bhavani1, S R Rathinam1, V R Muthukkaruppan1.   

Abstract

Leptospirosis is a widespread zoonotic disease that affects all mammals in different parts of the world. Though there are many commercial kits available for the diagnosis of systemic leptospirosis, the nature of the antigen has not been described. Therefore, identification of a specific antigen is important. Since ocular involvement in leptospirosis has been reported, there is a need to identify and characterize the leptospiral antigen for diagnosis of uveitis associated with past leptospiral infection (leptospiral uveitis) and for confirming the clinical diagnosis. Seven-day-old culture of Leptospira biflexa serovar Patoc was used for preparing the antigen. The present study included serum samples from 81 patients with clinical criteria for leptospiral uveitis, 15 cataract controls and 15 non-leptospiral uveitis controls. Serum samples were assayed by ELISA using our antigenic preparation and by a microscopic agglutination test (MAT) using 19 serovars. The antigen prepared had 280 micro g LPS ml(-1) and no detectable amount of protein. Silver-staining of SDS-PAGE for protein and LPS, dot blot and Western blot analysis and proteinase K and periodate treatment showed that LPS (13-21 kDa and 28 kDa) in our preparation was the relevant antigen for serodiagnosis. IgG antibodies showed reactivity in both leptospiral uveitis patients and controls. However, on the basis of IgM response to LPS, 48 % of the leptospiral uveitis patients were significantly positive compared with controls; 58 % of leptospiral uveitis patients and none of the controls were positive for MAT. When MAT and IgM ELISA results were considered together, 77 % were significantly positive. LPS is identified as a candidate antigen for serodiagnosis of leptospiral uveitis and has sensitivity and specificity of 48 and 90 %, respectively, in ELISA for IgM antibodies. Confirmation of clinical diagnosis with a specific laboratory test would help to initiate the most appropriate treatment for leptospiral uveitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867560     DOI: 10.1099/jmm.0.05120-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  LruA and LruB antibodies in sera of humans with leptospiral uveitis.

Authors:  Ashutosh Verma; S R Rathinam; C Gowri Priya; V R Muthukkaruppan; Brian Stevenson; John F Timoney
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

2.  Lateral flow assay for rapid serodiagnosis of bovine leptospirosis.

Authors:  K Senthilkumar; G Ravikumar
Journal:  Iran J Vet Res       Date:  2022       Impact factor: 1.226

3.  Early diagnosis of leptospirosis by immunoglobulin M immunoblot testing.

Authors:  Galayanee Doungchawee; Uraiwan Kositanont; Anuchai Niwetpathomwat; Tasanee Inwisai; Plyyonk Sagarasaeranee; David A Haake
Journal:  Clin Vaccine Immunol       Date:  2008-01-09

4.  Leptospirosis vaccines.

Authors:  Zhijun Wang; Li Jin; Alicja Wegrzyn
Journal:  Microb Cell Fact       Date:  2007-12-11       Impact factor: 5.328

5.  Identification of cattle, buffaloes and rodents as reservoir animals of Leptospira in the District of Gampaha, Sri Lanka.

Authors:  D T H Denipitiya; N V Chandrasekharan; W Abeyewickreme; R A Hartskeerl; M D Hapugoda
Journal:  BMC Res Notes       Date:  2017-03-23

6.  Lipopolysaccharide Specific Immunochromatography Based Lateral Flow Assay for Serogroup Specific Diagnosis of Leptospirosis in India.

Authors:  Shanmugam Vanithamani; Santhanam Shanmughapriya; Ramasamy Narayanan; Veerapandian Raja; Murugesan Kanagavel; Karikalacholan Sivasankari; Kalimuthusamy Natarajaseenivasan
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.